Image

A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.

A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.

Non Recruiting
7-17 years
All
Phase N/A

Powered by AI

Overview

The feasibility of using an electronic tool to measure pain, nausea, and vomiting after surgery in English or Spanish-speaking pediatric cancer patients.

Description

Primary Objective:

To determine the feasibility of administering an AR-based electronic tool to assess postoperative pain, nausea, and vomiting in English or Spanish-speaking pediatric patients with neoplastic conditions.

Secondary Objectives:

  1. To evaluate the willingness to use the AR app,
  2. To evaluate the time spent using the AR app (recorded in the study device),
  3. To calculate the difference (delta) between pain and nausea intensity recorded from the app and those gathered by nursing personnel,
  4. To evaluate app recorded responses to pain intensity,
  5. To evaluate app recorded responses to nausea intensity,
  6. To assess the frequency of vomiting,
  7. To measure the length of stay in PACU (calculated from the EMR),
  8. To determine the rate (number) of assessments completed,
  9. To calculate PACU opioid use,
  10. To calculate opioid use during hospitalization,
  11. To assess the quality of life using the PedsQL Cancer Module survey responses (administered by the study team),
  12. To evaluate patient/caregiver satisfaction following the PACU stay
  13. To assess nursing experience with AR tool following patient discharge from PACU.

Exploratory Objectives:

  1. To assess the primary/secondary outcomes for the English and Spanish-speaking patients separately.
  2. To correlate pain-reported intensity to the analgesia nociception index (ANI).

Eligibility

Inclusion Criteria:

  1. Ages 7-17 years old,
  2. Able to provide assent, and a legal guardian able to provide informed consent
  3. Current diagnosis of pediatric cancer or benign neoplasm,
  4. Surgery with an estimated duration longer than 2 hours,
  5. An expected prescription of opioids during the inpatient perioperative period
  6. Demonstrate capacity to comprehend and interact with the game in English or Spanish.

Exclusion criteria:

  1. Any concerns from the principal investigator or primary team about the use of the app,
  2. Inability or refusal from the parents to provide written informed consent.

Study details
    Neoplastic Conditions

NCT05933252

M.D. Anderson Cancer Center

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.